Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo

NCT00282178 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Obesity

Interventions

DRUG: Hydrochlorothiazide
DRUG: Placebo
DRUG: Candesartan

Sponsor

Umeå University

Collaborators

[object Object]
[object Object]